NCT00405613

Brief Summary

The purpose of this study is to determine if aspirin is associated with bleeding complications following a single tooth extraction

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started May 2003

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2003

Completed
2.6 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2005

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 30, 2006

Completed
Last Updated

April 25, 2022

Status Verified

November 1, 2006

First QC Date

November 28, 2006

Last Update Submit

April 19, 2022

Conditions

Bleeding Complication

Keywords

AspirinBleedingClinical TrialDental Extraction

Outcome Measures

Primary Outcomes (1)

  • Oral bleeding time

Secondary Outcomes (1)

  • Report of bleeding at phone follow-up at 3-7 (first follow-up) and 40-55 hours (second follow-up)

Interventions

AspirinDRUG

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy
  • Require a simple tooth extraction

You may not qualify if:

  • Use of previous aspirin or NSAID

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Carolinas Medical Center

Charlotte, North Carolina, 28232, United States

Location

MeSH Terms

Conditions

Hemorrhage

Interventions

Aspirin

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

SalicylatesHydroxybenzoatesPhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Officials

  • Michael T Brennan, DDS,MHS

    Carolinas Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2006

First Posted

November 30, 2006

Study Start

May 1, 2003

Study Completion

December 1, 2005

Last Updated

April 25, 2022

Record last verified: 2006-11

Locations

US(1)